Switzerland-based NBE Therapeutics AG, a biopharmaceutical company, announced a $20 million extension of series B funding led by Novo Holdings. Earlier in the series B funding round, the company had received $20 million, bringing the total funding to $40 million. The Swiss startup will use the new funding for the testing of the anti-ROR1 antibody-drug conjugate (ADC) NBE-002 in patients with solid tumors.
Sanford Health, a healthcare delivery system acquired the Evangelical Lutheran Good Samaritan Society, a senior healthcare services provider for an undisclosed amount. Both South Dakota based healthcare providers announced the merge to form a $6 billion company with 47,000 employees nationwide.
A research team from the University of California, Los Angeles, United States has revealed that deep learning (a form of AI) can distinctively increase microscopic resolutions in photos taken via smartphones.
A shocking report revealed that an error in breast cancer screening tests may have affected a vast number of women across England. Due to a computer algorithm failure dating back to 2009, a group of women was not sent for routine breast cancer screening tests before their 71st birthdays. Public Health England (PHE) predicted that around 450,000 women may have been affected due to these screening errors during 2009.
Babylon’s system initiates with a conversation and continues into an AI-assisted telemedicine visit. Apart from physician’s conversation with the patient, the system generates visit notes for the physicians. Even the patient’s facial expressions were analyzed and reported to the doctor. Babylon is working on the Alexa app, which would be released by the end of August.
Saving lives through accurate diagnosis followed by swift treatment is the major outcome of new and pioneering medical inventions and technologies. And it is encouraging to see that the healthcare industry is heading towards this goal. With this in mind, we have listed three medical advances which have helped to change the medical scenario throughout the world.
Philadelphia-based Carisma Therapeutics bagged $53 million in series A funding, led by AbbVie Ventures Co-led by HealthCap, new backers Wellington Partners, MRL Ventures Fund, TPG Biotech, and Agent Capital.
Scientists from the Melbourne Walter and Eliza Hall Institute and the Howard Hughes Medical Institute (US) have discovered a new vaccine for malaria, revealing an 'atomic-scale' blueprint of how the parasite seize human cells using a new technology called CRYO-EM (cryo-electron microscopy).
A new research collaborative study by Sensorion and UConn Health, presented at the 53rd American Neurotology Society Annual Spring Meeting, revealed the first potential biomarker for noise-induced hearing loss. The research team analyzed blood samples to check the level of serum prestin. The severity of hearing loss would be dependent upon the level of prestin circulated in the blood associated with the changes in an outer hair cell protein.
RET-driven cancers include medullary and papillary thyroid cancer, non-small cell lung cancer, colorectal and bile duct cancer, which have been very difficult to treat till date. Chemotherapy has been the only available treatment but leads to multiple side effects.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.